Hingoli, India

Chandrashekhar Kandi

This inventor holds 4 USPTO granted patents. Top assignee: Wockhardt Limited. Active years: 2012-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chandrashekhar Kandi. Retrieved from https://idiyas.com/inventor/chandrashekhar-kandi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012-2016

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Chandrashekhar Kandi

Introduction

Chandrashekhar Kandi is a notable inventor based in Hingoli, India. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on developing innovative pharmaceutical compositions that enhance the efficacy of various medications.

Latest Patents

Among his latest patents, one includes pharmaceutical compositions of duloxetine. This invention relates to the formulations of duloxetine or its pharmaceutically acceptable salts, along with the processes for their preparation. Another significant patent is for sustained release compositions of alfuzosin. This invention involves sustained release formulations that include alfuzosin or its pharmaceutically acceptable salts, incorporating one or more functional layers with rate-controlling polymers.

Career Highlights

Chandrashekhar Kandi is associated with Wockhardt Limited, a prominent pharmaceutical company. His work at Wockhardt has allowed him to contribute to the development of advanced pharmaceutical products that address various health issues.

Collaborations

He has collaborated with notable coworkers such as Girish Kumar Jain and Amit Gupta, enhancing the innovative capacity of his projects.

Conclusion

Chandrashekhar Kandi's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective medication formulations. His patents reflect a deep understanding of pharmaceutical science and a dedication to advancing medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…